Swiss National Bank - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 81 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 0.02 and the average weighting 0.7%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,099,008
-26.8%
86,400
-19.0%
0.00%0.0%
Q2 2023$1,502,336
-13.7%
106,700
-5.3%
0.00%0.0%
Q1 2023$1,741,215
+9.7%
112,700
+16.4%
0.00%0.0%
Q4 2022$1,586,552
-9.0%
96,800
+2.8%
0.00%0.0%
Q3 2022$1,743,000
+60.1%
94,200
+13.8%
0.00%0.0%
Q2 2022$1,089,000
+21.4%
82,800
-14.5%
0.00%0.0%
Q1 2022$897,000
+2.5%
96,800
+8.0%
0.00%0.0%
Q4 2021$875,000
-71.3%
89,6000.0%0.00%
-50.0%
Q3 2021$3,045,000
-6.5%
89,600
+0.8%
0.00%0.0%
Q2 2021$3,255,000
-14.2%
88,900
+5.1%
0.00%
-33.3%
Q1 2021$3,793,000
-19.8%
84,600
+2.1%
0.00%0.0%
Q4 2020$4,731,000
+12.1%
82,900
+0.7%
0.00%0.0%
Q3 2020$4,222,000
-10.2%
82,300
+4.6%
0.00%
-25.0%
Q2 2020$4,700,000
+130.6%
78,700
+59.0%
0.00%
+100.0%
Q1 2020$2,038,000
-30.2%
49,500
+5.5%
0.00%
-33.3%
Q4 2019$2,919,000
+88.2%
46,900
+2.6%
0.00%
+50.0%
Q3 2019$1,551,000
+179.5%
45,700
+85.8%
0.00%
+100.0%
Q2 2019$555,000
-12.7%
24,600
-10.2%
0.00%0.0%
Q1 2019$636,000
+14.0%
27,400
+3.0%
0.00%0.0%
Q4 2018$558,000
-43.9%
26,600
+3.5%
0.00%0.0%
Q3 2018$995,000
-1.6%
25,7000.0%0.00%0.0%
Q2 2018$1,011,00025,7000.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders